The Improved Experience You’ve Been Waiting For!
Discover the refreshed menu, enjoy the custom dashboard, and make use of the powerful stock screener to enhance your investment approach.
Explore Now
Based on the Bhagiradha Chemicals & Industries Limited stock forecast from 0 analysts, the average analyst target price for Bhagiradha Chemicals & Industries Limited is not available over the next 12 months. Bhagiradha Chemicals & Industries Limited’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Bhagiradha Chemicals & Industries Limited is Bearish, which is based on 3 positive signals and 11 negative signals. At the last closing, Bhagiradha Chemicals & Industries Limited’s stock price was INR 357.27. Bhagiradha Chemicals & Industries Limited’s stock price has changed by 0% over the past week, +38.95% over the past month and +162.63% over the last year.
No recent analyst target price found for Bhagiradha Chemicals & Industries Limited
No recent average analyst rating found for Bhagiradha Chemicals & Industries Limited
Company Overview Bhagiradha Chemicals & Industries Limited
Bhagiradha Chemicals & Industries Limited manufactures and sells crop protection chemicals in India, Asia, Australia, and Europe. The company offers insecticides, such as chlorpyrifos, chlorpyrifos-methyl, diafenthiuron, fipronil, dinotefuran, thiamethoxam, imidacloprid, pymetrozine, and chlorantraniliprole; fungicides, including azoxystrobin and trifloxystrobin; herbicides comprising triclopyr, cloquintocet-mexyl, clodinafop-propargyl, sulfosulfuron, and pinoxaden; and specialty intermediates, such as 2,6-dichloroaniline and 2-ethylsulfonylimidazo pyridine-3-sulfonamide. Bhagiradha Chemicals & Industries Limited was incorporated in 1993 and is headquartered in Hyderabad, India. Address: 8-2-269/S/3/A, Plot No. 3, Sagar Society, Hyderabad, India, 500034 Read Less
Bhagiradha Chemicals & Industries Limited manufactures and sells crop protection chemicals in India, Asia, Australia, and Europe. The company offers insecticides, such as chlorpyrifos, chlorpyrifos-methyl, diafenthiuron, fipronil, dinotefuran, thiamethoxam, imidacloprid, pymetroz...Read More
Stock Target Advisor's fundamental analysis for Bhagiradha Chemicals & Industries Limited's stock is Bearish.
BHAGCHEM:NSE stock's dividend yield is 0.03%.
Our analysis grades BHAGCHEM:NSE stock's dividend yield at F. This means that BHAGCHEM:NSE stock's dividend yield is above 7% of the stocks in the Agricultural Inputs sector in the NSE exchange.
Based on this BHAGCHEM:NSE may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on BHAGCHEM:NSE's stock to indicate what its average analyst target is.
BHAGCHEM:NSE stock's Price/Earning ratio is 2,439.80.
Our analysis grades BHAGCHEM:NSE stock's Price / Earning ratio at F. This means that BHAGCHEM:NSE stock's Price/Earning ratio is above 98% of the stocks in the Agricultural Inputs sector in the NSE exchange.
Based on this BHAGCHEM:NSE may be a overvalued for its sector.
The last closing price of BHAGCHEM:NSE's stock was INR 357.27.
The most recent market capitalization for BHAGCHEM:NSE is INR 45.54B.
Unfortunately we do not have enough analyst data on BHAGCHEM:NSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Bhagiradha Chemicals & Industries Limited's stock.
As per our most recent records Bhagiradha Chemicals & Industries Limited has 0 Employees.
Bhagiradha Chemicals & Industries Limited's registered address is Plot No. 3, Sagar Society, Hyderabad, India, 500034.
You can get more information about it from Bhagiradha Chemicals & Industries Limited's website at https://www.bhagirad.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BHAGCHEM:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
